Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The present study investigated the mechanism by which eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) inhibit platelet activation induced by thromboxane A 2. DHA was found to be more potent than EPA in blocking platelet aggregation induced by the stable thromboxane A 2 mimetic, U46619. Furthermore, this inhibition by DHA or EPA was competitive. Binding studies using 3 H‐U46619 demonstrated that both EPA and DHA interact with the platelet thromboxane receptor. The potency of the inhibition of binding corresponded with that seen for the inhibition of aggregation. These results suggest that thromboxane receptor antagonism may be an important mechanism by which EPA and DHA modulate platelet reactivity in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Inverse Relation between Fish Consumption and 20-Year Mortality from Coronary Heart Disease
Kromhout, D., Bosschieter, E. B., & Coulander, C. D. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505093121901 · Cited by 2,177
Cited by
Kinsella, J., Lokesh, B., & Stone, R. (1990) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/52.1.1 · Cited by 718
de Roos, B., Mavrommatis, Y., & Brouwer, I. A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00189.x · Cited by 151
Wachira, J. K., Larson, M. K., & Harris, W. S. (2014) · British Journal of Nutrition · doi:10.1017/s000711451300425x · Cited by 91
“Similar EPA- and DHA-mediated reductions were also noted in platelet thromboxane production((42,52,61,62)) and the competition for thromboxane receptor occupancy((63,64)).”
Sakamoto, A., Saotome, M., Iguchi, K., & Maekawa, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20164025 · Cited by 73
“The n-3 PUFA is reported to suppress the synthesis of platelet-derived thromboxane A2 (TXA2), which causes platelet aggregation and vasoconstriction [108], and to increase the plasminogen activator inhibitor-1 with reduction of fibrinogen [109].”
BackgroundDietary and Pharmacological Fatty Acids and Cardiovascular Health
Wu, H., Xu, L., & Ballantyne, C. M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz174 · Cited by 59
Metadata
- Authors
- Swann, P. G., Venton, D. L., & Le Breton, G. C.
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 1989-01-30
- Volume
- 243
- Issue
- 2
- Pages
- 244-246
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W2043312478
- Cited by
- 79
- References
- 1
- FWCI
- 6.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets. https://app.cochat.ai/papers/10.1016/0014-5793(89)80137-1
- The paper
- Swann, P. G., Venton, D. L., & Le Breton, G. C. (1989). Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets. FEBS Letters. https://doi.org/10.1016/0014-5793(89)80137-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.